Hospital

Recent estimates indicate that less than 10% of patients who are at risk for acquiring HIV are prescribed PrEP.

Ed Cohen, PharmD, FAPhA, executive vice president of pharmacy advocacy for the publication, was recognized with the prestigious Individual Advocate of the Year award.

These professional organizations are aware that some medications are being prophylactically prescribed as potential treatments for COVID-19.

The EUA designation allows the test to be used to detect SARS-CoV-2, the virus that causes COVID-19, for the duration of the continuing pandemic.

While remdesivir is not FDA-approved to treat the novel coronavirus, the orphan drug status would provide 7 years of exclusive marketing in the United States and tax credits on research and development costs once the drug was approved.

Gunda Siska, RPh, PharmD, discusses what she is doing as a hospital pharmacist to stay healthy.

The new guidelines recommend dosing vancomycin to achieve an area under the curve to minimum inhibitor concentration (AUC/MIC) ratio of ≥ 400.

Not enough people are taking seriously frequent recommendations to practice social distancing, he said.

The COVID-19 High Performance Computing Consortium is a partnership of federal government, tech industry, and academic leaders whose goal is to stop the virus.

Only 15% of those at risk are currently using PrEP.

The 12 groups represent practice settings of nearly all pharmacists in the United States.

A new report from the CDC has found that a significant portion of hospitalizations in the United States have come from younger adults.

Marilyn Bulloch, PharmD, BCPS, FCCM, shares her perspective of how the global COVID-19 pandemic is impacting pharmacy in her Alabama community.

Top news of the week from Pharmacy Times surrounding the novel coronavirus.

Chloroquine and remdesivir are not FDA-approved for a COVID-19 indications.

The researchers found that the average yearly out-of-pocket spending by patients with diabetes is over $1,800.

The availability of personal protective equipment, including face masks, gloves and hand sanitizers, have been a concern to many pharmacists.

The goals of the expansion are to maintain social distancing and to avoid overburdening hospitals with patients.

Aimmune’s peanut allergen power was approved by the FDA as an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut.

The new guidance for industry (GFI) document, “Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products,” was released Saturday.

In its first action, the FDA has decided to not object to the New York State Department of Health’s (NYSDOH) action authorizing certain laboratories in New York to start patient testing for COVID-19.

Illustrating how pharmacists improve the lives of others in the health environment, and using data to back that up are the 2 most necessary steps in gaining approval for a new hire.

Cannabis is comprised of over 480 compounds and 70 distinct cannabinoids, but tetrahydrocannabinol (THC) and cannabidiol (CBD) are the 2 most commonly used.

Novel approaches such as telemedicine may be a way to reach rural patients with cancer, according to a panel discussion at the Hematology/Oncology Pharmacists Association 2020 Meeting

Lesbian, gay, bisexual, transgender, and queer (LGBTQ) patients with cancer face specific barriers when seeking medical care, but pharmacists and other medical professionals can take specific steps to reduce the gaps in care.

Some of the candidates are approved by the FDA for other indications, but the majority of the agents are not currently commercially available in the United States for therapeutic use.

Service outcomes will be optimized by considering a constellation of factors besides the service itself, such as social support and patient self-efficacy.

In the United States, the CDC has confirmed 938 cases and 29 deaths, as well as 771 patients under investigation.

As vaping continues to grow in popularity, it becomes increasingly critical to correct misconceptions about its safety and long-term effects.

The FDA is taking action against companies that claim to treat or prevent the virus.